
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
hnRNP E1 CRISPR/Cas9 KO Plasmid (m) | sc-423930 | 20 µg | $397.00 |
Pcbp1 encodes the mouse heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1), an RNA-binding protein that recognizes C-rich elements to control mRNA stability and translation. hnRNP E1 participates in post-transcriptional gene regulation linked to cell-cycle progression, stress responses, and differentiation by shaping the availability of transcripts in the cytoplasm and their translation at ribosomes. Through its roles in RNA processing and translational control, hnRNP E1 influences pathways associated with epithelial–mesenchymal transition, cytoskeletal remodeling, and signaling-dependent gene expression programs. Dysregulated PCBP1/hnRNP E1 activity has been associated with altered RNA homeostasis and phenotypes relevant to tumor biology and inflammatory signaling in experimental models.
hnRNP E1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Pcbp1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Pcbp1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Pcbp1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish hnRNP E1 protein expression.
This CRISPR knockout system enables efficient generation of Pcbp1-deficient cell models for investigation of hnRNP E1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.